ATE431155T1 - Formulierungen mit extrakten aus cynara scolymus und phaseolus vulgaris zur behandlung von adipositas - Google Patents

Formulierungen mit extrakten aus cynara scolymus und phaseolus vulgaris zur behandlung von adipositas

Info

Publication number
ATE431155T1
ATE431155T1 AT07425132T AT07425132T ATE431155T1 AT E431155 T1 ATE431155 T1 AT E431155T1 AT 07425132 T AT07425132 T AT 07425132T AT 07425132 T AT07425132 T AT 07425132T AT E431155 T1 ATE431155 T1 AT E431155T1
Authority
AT
Austria
Prior art keywords
cynara scolymus
phaseolus vulgaris
obesity
formulations
treatment
Prior art date
Application number
AT07425132T
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Andrea Giori
Paolo Morazzoni
Cesare Ponzone
Massimo Ronchi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE431155T1 publication Critical patent/ATE431155T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT07425132T 2007-03-07 2007-03-07 Formulierungen mit extrakten aus cynara scolymus und phaseolus vulgaris zur behandlung von adipositas ATE431155T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07425132A EP1967198B1 (de) 2007-03-07 2007-03-07 Formulierungen mit Extrakten aus Cynara scolymus und Phaseolus vulgaris zur Behandlung von Adipositas

Publications (1)

Publication Number Publication Date
ATE431155T1 true ATE431155T1 (de) 2009-05-15

Family

ID=38229761

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07425132T ATE431155T1 (de) 2007-03-07 2007-03-07 Formulierungen mit extrakten aus cynara scolymus und phaseolus vulgaris zur behandlung von adipositas

Country Status (20)

Country Link
US (2) US7887854B2 (de)
EP (1) EP1967198B1 (de)
JP (1) JP5355424B2 (de)
KR (1) KR101456555B1 (de)
CN (1) CN101641111B (de)
AT (1) ATE431155T1 (de)
AU (1) AU2008224057B2 (de)
BR (1) BRPI0808563B1 (de)
CA (1) CA2680078C (de)
DE (1) DE602007001128D1 (de)
DK (1) DK1967198T3 (de)
ES (1) ES2323815T3 (de)
HK (1) HK1121694A1 (de)
IL (1) IL200709A (de)
NO (1) NO339322B1 (de)
PL (1) PL1967198T3 (de)
PT (1) PT1967198E (de)
RU (1) RU2453323C2 (de)
SI (1) SI1967198T1 (de)
WO (1) WO2008107184A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052450A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
CN101874822A (zh) 2009-04-27 2010-11-03 玫琳凯有限公司 植物性抗痤疮制剂
EP2345646A1 (de) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Verwendung von Tricyclisch-Sesquiterpen-Lactonen zur Behandlung von Fettleibigkeit und zugehörigen Störungen sowie von nicht-therapeutisch behandelbaren Zuständen
EP2567959B1 (de) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridin-4-carbonsäureamid-derivate als kinaseinhibitoren
KR101330190B1 (ko) 2011-09-20 2013-11-15 (주)그린솔루션스 하고초 추출물의 헴 옥시게나아제-1 발현 조절을 통한 지방 생성 억제용 화장료 조성물
EP3566691B1 (de) 2011-12-19 2024-04-17 Mary Kay Inc. Kosmetische verfahren zur hautaufhellung und hautton glättung mit adzukibohnen
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
ITMI20121727A1 (it) * 2012-10-12 2014-04-13 Indena Spa Formulazioni per il trattamento e la prevenzione dell'obesita'
ITMI20121749A1 (it) * 2012-10-16 2014-04-17 Indena Spa Estratti di helianthus annuus utili nel trattamento della sindrome metabolica e nella diminuzione dell'indice glicemico di alimenti e procedimento per la loro preparazione e composizioni che li contengono
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
DE202014005450U1 (de) * 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel
US20160302451A1 (en) * 2015-04-16 2016-10-20 Michael Hudnall Medical Food for Patients with Chronic Liver Disease
FR3075570B1 (fr) 2017-12-22 2020-01-03 Agro Innovation International Stimulation de la nitrification d'un sol avec des compositions comprenant un extrait de plante
IT201900000367A1 (it) * 2019-01-10 2020-07-10 Altergon Sa Composizioni comprendenti un peptide in grado di stimolare la via del segnale gprc6a-dipendente
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono

Also Published As

Publication number Publication date
ES2323815T3 (es) 2009-07-24
SI1967198T1 (sl) 2009-08-31
US20080220097A1 (en) 2008-09-11
US20100136145A1 (en) 2010-06-03
CA2680078A1 (en) 2008-09-12
RU2009133338A (ru) 2011-03-10
CN101641111B (zh) 2012-05-23
BRPI0808563A2 (pt) 2014-09-02
PT1967198E (pt) 2009-06-15
KR101456555B1 (ko) 2014-10-31
CA2680078C (en) 2016-12-06
DK1967198T3 (da) 2009-08-10
BRPI0808563B1 (pt) 2018-02-14
AU2008224057A1 (en) 2008-09-12
JP5355424B2 (ja) 2013-11-27
US7887855B2 (en) 2011-02-15
HK1121694A1 (en) 2009-04-30
DE602007001128D1 (de) 2009-06-25
NO339322B1 (no) 2016-11-28
PL1967198T3 (pl) 2009-10-30
IL200709A0 (en) 2010-05-17
WO2008107184A1 (en) 2008-09-12
NO20100527A1 (no) 2010-05-19
EP1967198B1 (de) 2009-05-13
JP2010520246A (ja) 2010-06-10
US7887854B2 (en) 2011-02-15
CN101641111A (zh) 2010-02-03
KR20090118051A (ko) 2009-11-17
AU2008224057B2 (en) 2012-07-19
EP1967198A1 (de) 2008-09-10
IL200709A (en) 2013-07-31
RU2453323C2 (ru) 2012-06-20

Similar Documents

Publication Publication Date Title
ATE431155T1 (de) Formulierungen mit extrakten aus cynara scolymus und phaseolus vulgaris zur behandlung von adipositas
CN101305973B (zh) 婴儿护肤用的山茶油
NO20076382L (no) Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer
UA116638C2 (uk) Композиція жирової суміші
TW200602031A (en) Antiinflammatory and pain-relieving agent for external, use
US11173181B2 (en) Camel hump-oil based herbal compositions and method of making the same
MX2009001156A (es) Composiciones de vitamina d y metodo de administracion a un ser humano.
WO2009065395A3 (de) Neue verwendung von omega-3-fettsäure(n)
RU2009105708A (ru) Способ лечения и профилактики кариеса зубов и гингивита
RU2013125980A (ru) Подсолнечник с низким содержанием насыщенных жиров и соответствующие способы
WO2010133377A8 (en) Fat blends and uses thereof
AR070339A1 (es) Metodos para mejorar la deposicion de dha y las funciones y/o el desarrollo relacionados con ella
ATE464879T1 (de) Fettlösliche drogengestaltung
Clasper The management of military wounds in the middle ages
FR2970152B1 (fr) Composition alimentaire a base d'extrait d'algues pour le traitement et/ou la prevention de la retinopathie diabetique
CN101053682B (zh) 刮痧专用增效精油
Stokes Treatment of steroid induced lipoatrophy with structural fat grafting
Regadas et al. Experimental model of human corpus cavernosum smooth muscle relaxation
GR20080100242A (el) Αλοιφη για εγκαυματα απο φυσικα συστατικα και μεθοδος παρασκευης
UA9747U (en) "boryslavskyi", wax agent
Song GuangWei et al. Research and development note: health-care safflower oil.
Amar et al. The Theriac of Medieval al-Shām
CN101675965A (zh) 一种治疗胃脘疼痛的半夏配方
BG109677A (bg) Етерични свещи с лечебен ефект
McQuade My experiences of Karigirii Leprosy centre: the author spent six weeks in the Schieffellin Institute of Health--Research and Leprosy Centre (SIH-R & LC, Karigiri) in Southern India, on work experience

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1967198

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 1967198

Country of ref document: EP